Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.
Lisa A
LA
Raedler
Blood. 2008 Mar 1;111(5):2516-20
17975015
Oncologist. 2013;18(1):37-45
23299776
Oncologist. 2013;18(1):27-36
23299777
Clin Cancer Res. 2013 Jul 1;19(13):3337-44
23515406
Br J Biomed Sci. 2013;70(3):110-20
24273897
BMJ Open. 2015 Nov 27;5(11):e009576
26614625